Navidea Biopharmaceuticals (NAVB) Stock Chart & Stock Price History $0.01 +0.01 (+1,566.67%) As of 05/12/2025 02:19 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsOptions ChainSEC FilingsTrendsBuy This Stock Navidea Biopharmaceuticals Stock Price Performance The Navidea Biopharmaceuticals (NAVB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 71.43%, with a year-to-date return of 9,900.00%. In the past month, the stock has increased 1,566.67%, reflecting recent market activity. As of the latest close, Navidea Biopharmaceuticals traded at $0.01 with a market cap of $1.00 million and volume of 703 shares. Five years ago, the stock traded at $0.96, representing a 98.96% decrease over that period. At the time, it had a market cap of $18.49 million and a volume of 96,100 shares. Receive NAVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1,566.67%1 Month Performance+1,566.67%3 Month Performance+1,328.57%Year-To-Date Performance+9,900.00%1 Year Performance-71.43%5 Year Performance-98.96% NAVB Stock Chart for Tuesday, May, 13, 2025 NAVB Chart by TradingView Navidea Biopharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/12/2025$0.00$0.01+1,566.67%$0.01$0.00703 shs$1.00 million05/09/2025$0.00$0.00$0.00$0.00596 shs$60,000.0005/08/2025$0.00$0.00$0.00$0.00988 shs$60,000.0005/06/2025$0.00$0.00$0.00$0.00230 shs$60,000.0005/05/2025$0.00$0.00-14.29%$0.00$0.00230 shs$60,000.0005/02/2025$0.00$0.00$0.00$0.001,597 shs$70,000.0005/01/2025$0.00$0.00+16.67%$0.00$0.001,597 shs$70,000.0004/30/2025$0.05$0.00-98.80%$0.01$0.003,409 shs$60,000.0004/29/2025$0.00$0.05+24,900.00%$0.05$0.0511,029 shs$5.00 million04/25/2025$0.00$0.00$0.00$0.00155,008 shs$20,000.00 Get the Latest News and Ratings for NAVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/24/2025$0.00$0.00-66.67%$0.00$0.00155,008 shs$20,000.0004/23/2025$0.00$0.00$0.00$0.00670 shs$60,000.0004/22/2025$0.00$0.00$0.00$0.001,025 shs$60,000.0004/18/2025$0.00$0.00$0.00$0.0025 shs$60,000.0004/17/2025$0.00$0.00$0.00$0.0025 shs$60,000.0004/15/2025$0.00$0.00$0.00$0.00311 shs$60,000.0004/14/2025$0.00$0.00$0.00$0.00311 shs$60,000.00 Related Companies Universe Pharmaceuticals Stock Chart Histogen Stock Chart Aditxt Stock Chart Vaxxinity Stock Chart Calithera Biosciences Stock Chart Scopus BioPharma Stock Chart Smart for Life Stock Chart Evelo Biosciences Stock Chart Genocea Biosciences Stock Chart Genocea Biosciences Stock Chart Receive NAVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NAVB) was last updated on 5/13/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredWarning: Massive IPO Predicted for May 14?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Navidea Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Navidea Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NAVB Stock Free NAVB Stock Alerts